Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-25 @ 9:22 PM
Study NCT ID:
NCT00336856
Status:
COMPLETED
Last Update Posted:
2016-07-12
First Post:
2006-06-12
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Irinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy
Sponsor:
University of Pittsburgh
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-06
Start Date Type:
None
Primary Completion Date:
2011-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-06
Completion Date Type:
ACTUAL
First Submit Date:
2006-06-12
First Submit QC Date:
None
Study First Post Date:
2006-06-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-01-12
Results First Submit QC Date:
None
Results First Post Date:
2016-07-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-06-01
Last Update Post Date:
2016-07-12
Last Update Post Date Type:
ESTIMATED